$-0.07 EPS Expected for OHR Pharmaceutical, Inc. (OHRP)

Retrieved on: 2018-01-16 10:37:30

Tags for this article:

Money

Finance

Economy

NASDAQ

Short

Economy of New York City

N share

Office for Human Research Protections

Squalamine

Click the tags to see associated articles and topics

$-0.07 EPS Expected for OHR Pharmaceutical, Inc. (OHRP). View article details on hiswai:

Excerpt

<div>Blackrock, a New York-based fund reported 417,975 shares. Sabby Ltd has invested 0.01% in OHR Pharmaceutical, Inc. (NASDAQ:OHRP). <b>Renaissance</b> <b>Technologies</b> reported 788,409 shares stake. Citadel Ltd Liability accumulated 25,501 shares or 0% of the stock. United Advisers Ltd Limited Liability ...</div>

Article found on:

View Original Article